Buffalo, NY, United States of America

Ralph Benedict

This inventor holds 1 USPTO granted patent. Top assignee: Biogen Idec Ma Inc.. Active years: 2017.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ralph Benedict: Innovator in Multiple Sclerosis Evaluation

Introduction

Ralph Benedict is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of medical technology, particularly in the evaluation and treatment of multiple sclerosis. His innovative work has led to the development of a patent that addresses critical aspects of this debilitating condition.

Latest Patents

Ralph Benedict holds a patent for "Cognitive composite parameters and uses thereof for evaluating multiple sclerosis." This patent encompasses methods, systems, and kits designed for the identification, assessment, and treatment of individuals suffering from multiple sclerosis. His work in this area is crucial for improving patient outcomes and advancing medical research.

Career Highlights

Benedict is associated with Biogen Idec Ma Inc., a leading biotechnology company focused on developing therapies for neurological diseases. His role at Biogen Idec Ma Inc. allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Jeffrey A. Wilken and Frederick W. Foley. Their collective expertise enhances the innovative environment at Biogen Idec Ma Inc., fostering advancements in the treatment of neurological disorders.

Conclusion

Ralph Benedict's contributions to the field of multiple sclerosis evaluation through his patent and work at Biogen Idec Ma Inc. highlight his commitment to improving healthcare solutions. His innovative spirit continues to inspire advancements in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…